SAR366234
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SAR366234, covering 2016-04-27 to 2016-04-27. Get the full timeline:
Most recent: Clinical Trial Update: 28-Day Repeated Topical Study to Evaluate the Safety and Activity of 5 Escalating Dose Levels of SAR366234 and One Dose of Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension [Phase 1]